← Evidence map

ArticleAdvances in therapy2023

Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis".

Jonathan Marshall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis". | Socratic